Bone marrow stem cell treatment in heart failure patients
Abstract
Chronic heart failure (CHF) treatment is an important problem of modern cardiology, with only one radical, but not universally possible solution – heart transplantation. Regenerative myocardial therapy, stem cell transplantation, raises increasing interest recently, due to many researchers’ doubts on genetic therapy for coronary heart disease and CHF management.
About the Authors
Yu. I. Buziashvili
A.N. Bakoulev Research Center for Cardiovascular Surgery, Russian Academy of Medical Science, Moscow
Russian Federation
Russian Federation
S. T. Matskeplishvili
A.N. Bakoulev Research Center for Cardiovascular Surgery, Russian Academy of Medical Science, Moscow
Russian Federation
Russian Federation
D. Kh. Kamardinov
A.N. Bakoulev Research Center for Cardiovascular Surgery, Russian Academy of Medical Science, Moscow
Russian Federation
Russian Federation
M. B. Usherzon
A.N. Bakoulev Research Center for Cardiovascular Surgery, Russian Academy of Medical Science, Moscow
Russian Federation
Russian Federation
M. R. Grigoryan
A.N. Bakoulev Research Center for Cardiovascular Surgery, Russian Academy of Medical Science, Moscow
Russian Federation
Russian Federation
L. A. Bokeriya
A.N. Bakoulev Research Center for Cardiovascular Surgery, Russian Academy of Medical Science, Moscow
Russian Federation
Russian Federation
References
1. Беленков Ю.Н., Мареев В.Ю. Рекомендации по рациональному лечению больных сердечной недостаточностью. Cons med 1999; 3: 109-11.
2. Беленков Ю.Н., Мареев В.Ю. Рекомендации по рациональному лечению больных сердечной недостаточностью. Cons med 1999; 3: 111-5.
3. Беленков Ю.Н., Агеев Ф.Т., Мареев В.Ю. Парадоксы сердечной недостаточности: взгляд на проблему на рубеже веков. Кардиология 2000; 1: 4-10.
4. Бокерия Л.А., Бузиашвили Ю.И., Мацеплишвили С.Т. и др. Первый опыт использования аутологиных клеток костного мозга при лечении сердечной недостаточности ишемического генеза и острого инфаркта миокарда. Бюлл НЦССХ им. А.Н. Бакулева РАМН 2004; 5(4): 152-9.
5. Чертков И.Л., Дризе Н.И. «Пластичность» костно-мозговых стволовых клеток. Тер архив 2004; 7: 5-11.
6. Freedman SB. Therapeutic angiogenesis for coronary artery disease. Ann Intern Med 2002; 136(1): 54-71.
7. Hamaway AH, Lee LY, Crystal RG, et al. Cardiac agiogenesis and gene therapy: A strategy for myocardial revascularization. Curr Opin Cardiol 1999; 14: 515-22.
8. Hudlicka O, Brown MD, Walter H, et al. Factors involved in capillary growth in the heart. Mol Cell Biochem 1995; 147(1-2): 57-68.
9. Losordo DW, Vale PR, Symes JF, et al. Gene therapy for myocardial angiogenesis: initial clinical results with direct myocardial injection of ph VEGF 165 as sole therapy for myocardial ischaemia. Circulation 1998; 98: 2800-4.
10. Post M, Ware JA. Angiogenesis in atherosclerosis and restenosis. In: Angiogenesis and cardivascular disease. New York, Oxford: Oxford University Press 1999.
Review
For citations:
Buziashvili Yu.I., Matskeplishvili S.T., Kamardinov D.Kh., Usherzon M.B., Grigoryan M.R., Bokeriya L.A. Bone marrow stem cell treatment in heart failure patients. Cardiovascular Therapy and Prevention. 2005;4(5):79-82. (In Russ.)
Views:
475
Email this article 
